Zhou Ya Bin, Xiao Yuan Yuan, Chao Jin Jing, Ma Lin
Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, People's Republic of China.
Clin Cosmet Investig Dermatol. 2021 Nov 25;14:1799-1803. doi: 10.2147/CCID.S342203. eCollection 2021.
Tinea capitis is a common dermatophytosis predominantly occurring in children, which needs oral antifungal drug therapy. Itraconazole pulse therapy has been widely applicated in the treatment of adult onychomycosis. However, only a few studies are available for the treatment of pediatric tinea capitis with itraconazole pulse therapy. The therapy schedules vary with respect to dose and intermission. Here, we report four cases of tinea capitis that were treated with a novel high-dose itraconazole pulse therapy (6-10 mg/kg/d with 3 weeks off between consecutive pulses). After 2-3 pulses therapy, all the patients were cured and no adverse reactions were observed. We demonstrate the efficacy and safety of this novel itraconazole pulse therapy schedule. It may be a promising therapy in the treatment of tinea capitis in children.
头癣是一种主要发生于儿童的常见皮肤癣菌病,需要口服抗真菌药物治疗。伊曲康唑冲击疗法已广泛应用于成人甲癣的治疗。然而,关于伊曲康唑冲击疗法治疗儿童头癣的研究较少。治疗方案在剂量和间歇期方面各不相同。在此,我们报告4例采用新型高剂量伊曲康唑冲击疗法(6 - 10mg/kg/d,连续两次冲击之间间隔3周)治疗的头癣病例。经过2 - 3次冲击治疗后,所有患者均治愈,且未观察到不良反应。我们证明了这种新型伊曲康唑冲击疗法方案的有效性和安全性。它可能是治疗儿童头癣的一种有前景的疗法。